Hans Arwidsson
Director Ejecutivo en EUROCINE VACCINES AB .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Nicklas Westerholm | M | 48 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 28 años |
Mats Hansen | M | 53 | 9 años | |
Oskar Axelsson | M | 62 | 17 años | |
Pierre Armand Morgon | M | 61 | 11 años | |
Kari Grønås | F | 59 | 6 años | |
Jan Nils Sandström | M | 86 | 12 años | |
Claes Tomas Post | M | 74 |
University of Uppsala
| 36 años |
Pär Thuresson | M | 64 | 20 años | |
Alan Henry Raffensperger | M | 64 | 1 años | |
Hanna Olsson | F | 44 | 5 años | |
Emanuele Montomoli | M | - | - | |
Tove Sivik Sonne | F | 44 | 11 años | |
Paul Hargreaves | M | 55 | 3 años | |
Carlos von Bonhorst | M | - | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Carl M. Svernlöv | M | - |
University of Uppsala
| 2 años |
Yvonne Sörberg | F | 55 |
Stockholm School of Economics
| 4 años |
Magnus Eriksson | M | - |
Stockholm School of Economics
| 1 años |
Robert Sjöström | M | 60 |
University of Uppsala
Stockholm School of Economics
| 7 años |
Henrik Paulsson | M | - |
University of Uppsala
| 2 años |
Sten Nilsson | M | 76 | 10 años | |
Peter Leander | M | 67 | 11 años | |
Emma Berglund Eng | F | - | - | |
Stig Olle Backman | M | 55 |
University of Uppsala
| 4 años |
Per Olof Kjell Johansson | M | 68 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 24 años |
Anna Levander | F | 47 |
Stockholm School of Economics
| 5 años |
John Knutsson | M | 54 |
Stockholm School of Economics
| 4 años |
Lea Bajc | F | - |
Stockholm School of Economics
| 4 años |
Karin Helena Johansson Wingstrand | F | 67 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 9 años |
Peter Benson | M | - |
Stockholm School of Economics
| 4 años |
Lars Birgerson | M | 71 |
University of Uppsala
| 16 años |
Jens Patrik Hedelin | M | 55 |
Stockholm School of Economics
| 4 años |
Kjell Göran Stenberg | M | 72 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 25 años |
Lars Anders Eriksson | M | 53 |
Stockholm School of Economics
| 5 años |
Curt Mikael von Euler-Chelpin | M | 71 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 10 años |
Lennart Ove Mikael Karlsson | M | 61 |
University of Uppsala
| 2 años |
Daniel Georg Winberg | M | 49 |
Stockholm School of Economics
| 5 años |
Måns Anders Alfvén | M | 50 |
Stockholm School of Economics
| 4 años |
Dag Erik Johan Svanstrom | M | 53 |
Stockholm School of Economics
| 1 años |
Johan Ragnar Fredrik Ulfsson Siwers | M | 55 |
Stockholm School of Economics
| 2 años |
Cecilia Tunberger | F | 48 |
Stockholm School of Economics
| 5 años |
Karin Kronhoffer | F | - |
University of Uppsala
| 5 años |
Gustav Nilsson | M | - |
Stockholm School of Economics
| 5 años |
Louise Welin | F | - |
University of Uppsala
| 1 años |
Ulf Gezelius | M | - |
Stockholm School of Economics
| 2 años |
Ulrika af Buren | F | - |
Stockholm School of Economics
| 2 años |
Alex Valcu | M | - |
Stockholm School of Economics
| 5 años |
Erik Savenstrand | M | 50 |
Stockholm School of Economics
| 4 años |
Erik Hjelmstedt | M | - |
Stockholm School of Economics
| 4 años |
Carl Eric Robin Ramm-Ericson | M | 49 |
Stockholm School of Economics
| 3 años |
Helene Depui Ekdal | F | 56 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 23 años |
Karin Henriksson | F | - |
University of Uppsala
| 1 años |
Jan Hermansson | M | 68 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 9 años |
Angela Langemar Olsson | F | 54 |
Stockholm School of Economics
| 5 años |
Mikael Anttila | M | - |
Stockholm School of Economics
| 1 años |
Marie Olliver | M | - | - | |
Jan Rikard Jonsson | M | 69 |
University of Uppsala
| 4 años |
Karl David Frykman | M | 52 |
Stockholm School of Economics
| 5 años |
Erik Wigertz | M | 53 |
Stockholm School of Economics
| 4 años |
Pekka Ilmari Lettijeff | M | 63 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 1 años |
Erik Hans Allan Törnberg | M | 54 |
Stockholm School of Economics
| 4 años |
Robin Thorn | M | - |
Stockholm School of Economics
| 4 años |
Anders I. Westin | M | 54 |
Stockholm School of Economics
| 1 años |
Indrek Rahumaa | M | 52 |
Stockholm School of Economics
| 4 años |
Peter Möller | M | 72 |
University of Uppsala
| 4 años |
Martin Tivéus | M | 53 |
Stockholm School of Economics
| 4 años |
Alf E. A. Lindberg | M | 85 | - | |
Stefan Jung | M | 61 |
University of Uppsala
| 4 años |
Mats Hovmöller | M | 52 |
Stockholm School of Economics
| 1 años |
Björn Magnus Sjöstrand | M | 56 | - | |
Per Hjalmar Olof Didrikson | M | 50 |
Stockholm School of Economics
| 4 años |
Eugen Steiner | M | 70 | 4 años | |
Lars Dahlgren | M | 54 |
Stockholm School of Economics
| 1 años |
Bo-Ragnar Tolf | M | 74 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | - |
Kjell Anders Thelin | M | 54 |
Stockholm School of Economics
| 4 años |
Fredrik Malm | M | 50 |
Stockholm School of Economics
| 1 años |
Hans Vestberg | M | 58 |
University of Uppsala
| 4 años |
Jörgen Lars Ekberg | M | 65 |
Stockholm School of Economics
| 14 años |
Mattias Maximilian Miksche | M | 56 |
Stockholm School of Economics
| 5 años |
Fredrik Druvefors | M | - |
Stockholm School of Economics
| 2 años |
Jonathan R. Macey | M | 68 |
Stockholm School of Economics
| 3 años |
Ein Stadalninkas | M | - |
Stockholm School of Economics
| 4 años |
Bo Lars Erik Verneholt | M | 56 |
Stockholm School of Economics
| 4 años |
Hans Rudolf Michael Mattsson | M | 51 |
Stockholm School of Economics
| 4 años |
Mathias Pedersen | M | 53 |
Stockholm School of Economics
| 4 años |
Carl David Engström | M | 47 |
Stockholm School of Economics
| 5 años |
Jakob Roland Tolleryd | M | 51 |
Stockholm School of Economics
| 5 años |
Tim Watts | M | 66 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 5 años |
Maija Dobele | F | 47 |
Stockholm School of Economics
| 4 años |
Christian Sievert | M | 55 |
Stockholm School of Economics
| 1 años |
Carl Wilhelm Gustaf Furstenbach | M | - |
Stockholm School of Economics
| 6 años |
David Smith | M | 58 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 8 años |
Micaela Sjökvist | F | 54 |
University of Uppsala
| 4 años |
Joakim Lundvall | M | - |
Stockholm School of Economics
| 4 años |
Stefan Persson | M | - |
University of Uppsala
| 3 años |
Magnus Agervald | M | 49 |
Stockholm School of Economics
| 3 años |
Stefan Gerhard Lambert | M | 60 |
Stockholm School of Economics
| 4 años |
Christian Pérez | M | 52 |
Stockholm School of Economics
| 4 años |
Niklas Nikita Sloutski | M | 48 |
Stockholm School of Economics
| 4 años |
Sten Kristoffer Melinder | M | 53 |
Stockholm School of Economics
| 4 años |
Goran Dahlin | M | 53 |
Stockholm School of Economics
| 5 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Suecia | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Hans Arwidsson
- Red Personal